AGAP2 and lung carcinoma: Totally, inhibition of AGAP2-AS1, macrophage-derived exosomes, and exosomes overexpressing AGAP2-AS1 or miR-296 facilitates the malignant phenotypes of radioresistant lung cancer cells.